Navigation Links
Many Heart Patients Place False Hope in Angioplasty
Date:9/8/2010

By Ellin Holohan
HealthDay Reporter

WEDNESDAY, Sept. 8 (HealthDay News) -- Many heart patients harbor the misguided notion that angioplasty, a common procedure to open clogged arteries, will also cut their risk of heart attacks and death, a new study shows.

In fact, the evidence suggests that angioplasty only reduces angina (cardiac-linked chest pain) in stable heart patients -- people whose condition has not changed recently and who are not experiencing a heart attack. The procedure does not reduce the risk of heart attack or death for these patients.

However, the new study found that 88 percent of stable patients who underwent angioplasty at a hospital in Massachusetts thought the procedure would reduce their risk of heart attack. And two-thirds of the patients didn't even suffer the kind of pain that angioplasty would likely remedy, the study authors noted.

Furthermore, most patients stuck to their beliefs even after spending time with a cardiologist who explained the risks and benefits to them, and had them sign an informed consent form prior to the angioplasty.

The study "shows the disconnect between what doctors know and what patients understand. In order to have real informed consent, patients have to understand not just the risks, but also the benefits of whatever treatment is proposed," said study author Dr. Michael Rothberg, of the Division of General Medicine and Geriatrics at Baystate Medical Center in Springfield, Mass.

The findings were published in the Sept. 7 issue of the Annals of Internal Medicine.

During angioplasty, a tube is inserted at the groin and snaked up to the affected artery, where a balloon opens the blockage. A stent (a flexible mesh tube) is often left in place to help prop open the artery and maintain blood flow. Angioplasty involves some risk but the rate of death during the procedure is less than 1 percent, experts note.

In the study, patients underwent catheter-based diagnostic procedures for a variety of reasons including a positive stress test, shortness of breath, a previous heart attack or other heart conditions.

Angioplasty is often performed at the same time if a blockage is found. Patient-informed consent for both procedures was required.

The study involved 153 patients with stable heart disease who had varying levels of symptoms. According to the authors, less than one-third (31 percent) of those who agreed to undergo elective cardiac catheterization had the type of activity-limiting angina pain that angioplasty might be expected to ease.

Nevertheless, almost three-quarters of all the patients still believed that if they didn't undergo angioplasty, they would suffer a heart attack within the next five years.

In contrast, 63 percent of cardiologists surveyed in the study realized that for stable heart patients, the procedure mainly reduces pain (from angina) and improves quality of life.

The authors also noted that these benefits can often be achieved with medication alone.

Only patients who are actually having a heart attack or coronary event can expect a reduced risk of future heart attacks and death from angioplasty, according to prior research cited in the study.

The number of angioplasties done for stable heart patients has, in fact, decreased lately, said Rothberg. According to the American Heart Association, about 1.3 million such procedures are done in the United States each year.

Dr. Henry H. Ting, associate dean for quality, and professor of medicine at the Mayo Clinic in Rochester, Minn., said he was not surprised by the study findings.

Ting pointed to a survey at the Mayo Clinic that found that 80 percent of patients signed consent forms they had not read, and did not know the benefits or risks of the treatment they were having.

Ting, who conducts research on informed consent, said the problem of patient understanding isn't limited to angioplasty but is common in many areas of medicine.

"We [doctors] don't do a good job of knowledge transfer in a way that patients and family members can understand," said Ting. "Graphs and charts are not going to work for many of our patients."

One reason for patients' misunderstanding is the common belief, cited in the study, that if a treatment is offered, it must have curative benefits.

And Dr. Gregg C. Fonarow, associate chief of the division of cardiology at the University of California, Los Angeles School of Medicine said that, "it's not counterintuitive for patients to conclude" that if angioplasty widens an artery it will reduce the risk of heart attacks and death, even though it is not true.

Fonarow, who is also professor of cardiovascular medicine and science at the school, contends that "the importance of this study is not that the patients should not have had the procedure." Instead, he said, the study highlights the different perspectives of doctors and their patients.

More information

Find out more about angioplasty at the U.S. National Heart Lung and Blood Institute.

SOURCES: Gregg C. Fonarow, M.D., professor, cardiovascular medicine and science, director, Ahmanson-UCLA Cardiomyopathy Center, associate chief, Division of Cardiology, University of California, Los Angeles; Henry H. Ting, M.D., interventionist cardiologist, associate dean for quality at Mayo Clinic, and professor, medicine, Mayo Clinic, Rochester, Minn.; Michael B. Rothberg, M.D., M.P.H., associate professor, medicine, Tufts University, Boston, and cardiologist, division of general medicine and geriatrics, Baystate Medical Center, Springfield, Mass.; Sept. 7, 2010, Annals of Internal Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. ICU Patients at Risk for Rare Heart Rhythm Problem
2. Cook With Love This Valentines Day With Heart-Smart Recipes
3. Study finds racial gaps continue in heart disease awareness
4. Highmark Foundation Awards $120,000 to the American Heart Association
5. Womens Heart Disease Awareness Still Lacking
6. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
7. Migraine Linked to Increased Heart Attack Risk
8. PERSONALABS Offers Discounted Healthy Heart Online Blood Tests in February
9. Compound shows promise against intractable heart failure
10. New American Heart Association Survey Finds Heart Disease and Stroke Patients Face Significant Barriers in Obtaining Quality, Affordable Care
11. Ex-President Clinton Undergoes Heart Procedure
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Many Heart Patients Place False Hope in Angioplasty
(Date:5/30/2016)... ... 30, 2016 , ... "This plugin comes with 60 customizable ... CEO of Pixel Film Studios. , TransPack Volume 7 features over 60 ... abstract transitions to more simple wipes with blur & drop shadow options. Utilize ...
(Date:5/30/2016)... ... May 30, 2016 , ... ... Shaolin warrior 8-day-8 and 8-night special intensive summer training camp starts on June ... summer camp offers families and children a fun and unique experience with an ...
(Date:5/29/2016)... ... May 29, 2016 , ... Whole Health Supply is happy to announce ... been available via Amazon.com. This new style of nail clipper has a wider jaw ... is approximately 4mm and the actual handle is 2.5mm thick to accommodate the cutting ...
(Date:5/29/2016)... ... , ... "With 30 unique self-animating web themed intros and complete control over ... said Christina Austin - CEO of Pixel Film Studios. , ProIntro Web Volume ... Final Cut Pro X. Pixel Film Studios’ minimalistic titles allow users to add a ...
(Date:5/28/2016)... Viejo, California (PRWEB) , ... May 28, 2016 , ... ... need to drag and drop a preset onto their media," said Christina Austin - ... Pixel Film Studios, editors can quickly and easily add stylish color grades to their ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 LabStyle ... Dario™ Diabetes Management Tool, today announced that the Company,s Chief ... Marcum MicroCap Conference being held June 1-2 in ... being held June 7-9 in Los Angeles, CA. ... discuss recent corporate and operational milestones, including the U.S. FDA ...
(Date:5/27/2016)... Hutchison China MediTech (Chi-Med) ... the highly lucrative global oncology and immunology markets. ... first-in-class or best-in-class tyrosine kinase inhibitor (TKI) drugs, ... partners. HCM,s profitable Chinese healthcare business continues to ... progress of the mid-to-late-stage pipeline during 2016-17 (including ...
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
Breaking Medicine Technology: